Ionis Pharmaceuticals, Inc. Deferred Income Tax Assets, Net
Ionis Pharmaceuticals, Inc. (IONS) had Deferred Income Tax Assets, Net of $0 as of 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2021-02-24
- 2020-12-31: Deferred Income Tax Assets, Net $0.00.
- 2020-09-30: Deferred Income Tax Assets, Net $307.74M.
- 2020-06-30: Deferred Income Tax Assets, Net $305.98M.
- 2020-03-31: Deferred Income Tax Assets, Net $309.61M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-24 |
| 2020-09-30 | $307.74M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $305.98M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $309.61M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $305.56M 10-K · filed 2021-02-24 |
| 2018-12-31 | $290.80M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |